Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
World Vitiligo Map
Your guide to the vitiligo community worldwide. Use the selector to filter by patient support groups, specialists, research centers, clinical trial locations, or World Vitiligo Day events.
Directory Information & Disclaimer
This free public directory gathers information from public sources to help connect our global community. Medical professionals and organizations listed are independent and not affiliated with or endorsed by the Vitiligo Research Foundation (VRF), and no fees are accepted for listings.
Because clinics, support groups, and specialists move or update their services over time, some information may occasionally become outdated. As a result, VRF cannot guarantee the complete accuracy or usefulness of listed third-party resources.
Help Us Keep the Map Accurate
Do you need to add a listing, update outdated details, or request a removal? Please reach out to us using the feedback form on our Contact Us page.
Search Map
78 records found for “NCT06804811” · show all
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Medical University Innsbruck, Innsbruck, 06020, Austria
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-1128 Diagnostic and Consultative Center, Sofia, 01528, Bulgaria
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Dermodent Centrum Medyczne Aldona Czajkowska Rafał Czajkowski, Osielsko, 86-031, Poland
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Psoriahue, Buenos Aires, 01425, Argentina
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Hospital Italiano de Buenos Aires, Buenos Aires, C1181ACH, Argentina
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Instituto de Neumonologia Y Dermatologia, Buenos Aires, C1425BEA, Argentina
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Consultorios Medicos Dr. Doreski, Buenos Aires, C1426ABP, Argentina
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Derma Internacional S.A., Buenos Aires, C1426, Argentina
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Universitaetsklinikum Graz, Graz, 08036, Austria
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Hopital Universitaire de Bruxelles (Academisch Ziekenhuis Brussel), Brussels, 01070, Belgium
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Universitair Ziekenhuis Gent, Ghent, 09000, Belgium
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Universitair Ziekenhuis Leuven, Leuven, 03000, Belgium
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Medical Center Asklepii Ood, Dupnitsa, 02600, Bulgaria
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Mhat Dr. Tota Venkova Ad, Gabrovo, 05300, Bulgaria
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Medical Center Unimed Eood, Sevlievo, 05400, Bulgaria
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Umhat Aleksandrovska, Sofia, 01431, Bulgaria
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Polyclinique de Courlancy, Reims, 51100, France
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Mc Euroderma Clinic, Sofia, 01606, Bulgaria
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Diagnostic Consultation Center Xx - Sofia Eood, Sofia, 01618, Bulgaria
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Herlev and Gentofte Hospital, Hellerup, 02900, Denmark
1.855.463.3463
FAQOther Questions
- What's the status with official recognition of World Vitiligo Day?
In 2016, the United Nations marked World Vitiligo Day in its International Calendar of Disability Events. However, it was removed in 2019 when the calendar was streamlined to 'M...
- Can Ayurveda help with vitiligo?
Ayurveda, the ancient Indian system of holistic medicine, focuses on balancing body energies (Doshas) and improving digestion. While it offers a valuable perspective on "whole-b...
- PTSD in Vitiligo?
Living with vitiligo often involves more than managing visible skin changes. Many individuals face discrimination, social stigma, and feelings of isolation, leading to emotional...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.